Nature

Current therapeutic landscape and future treatment perspectives of MASH

By Suchira Gallage, Olivier Govaere, Quentin Mark Anstee, Mathias F Heikenwälder

ReviewInterventions

The paper

Suchira Gallage, Olivier Govaere, Quentin Mark Anstee, Mathias F Heikenwälder

German Cancer Research Center

Nature, 2 Sep 2026

doi.org/10.1038/s41586-026-10672-8 PubMed 42687024

Nature Metabolism2 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Frontiers in Nutrition4 Oct 2026
Cardiometabolic burden is linked to CVD and death in MASLD
Hepatology International7 Oct 2026
Blood proteins linked aging measures to fatty liver disease risk
Frontiers in Nutrition9 Oct 2026
Moderate tea drinking linked to lower death risk in MASLD